These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 5610166

  • 21. [Evaluation of arrhythmia in patients with acute myocardial infarction receiving neoton (phosphocreatine)].
    Tomaszewski A, Markiewicz M, Dabrowski P, Baszak J, Jach A, Trojnar R, Wysokiński A.
    Wiad Lek; 1994 Aug; 47(15-16):570-3. PubMed ID: 7716951
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. [Debatable questions of strophanthin and spironolactone treatment in certain forms of acute myocardial infarct].
    Kun IS, Ostrovskaia VI, Abinder AA.
    Kardiologiia; 1980 Dec; 20(12):14-8. PubMed ID: 7206422
    [Abstract] [Full Text] [Related]

  • 24. [Tolerance to cardiotoxic effect of strophanthane K in experimental total heart block and electrocardiostimulation].
    Iskenderov BG.
    Eksp Klin Farmakol; 2001 Dec; 64(6):34-6. PubMed ID: 11871235
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Myocardial infarct and disorders of cardiac rhythm].
    Samson M.
    Union Med Can; 1968 Dec; 97(12):1817-8. PubMed ID: 5746577
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Reperfusion arrhythmias in acute myocardial infarction.
    Gao RL, Yao KB, Chen JL, Yang YJ, Xu YS, Chen ZJ.
    Chin Med J (Engl); 1993 Jul; 106(7):514-7. PubMed ID: 8243123
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Rhythm disorders in acute myocardial infarct at the National Hospital of Zavia in Libya over a 2-year period].
    Buksa M, Arslanagić A.
    Med Arh; 1983 Jul; 37(4):199-201. PubMed ID: 6400860
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Intramuscular strophanthin therapy].
    Iványi J.
    Z Arztl Fortbild (Jena); 1965 Apr 15; 59(8):452-5. PubMed ID: 5887307
    [No Abstract] [Full Text] [Related]

  • 35. [Determination of the effect of furanthril on myocardial infarct lesion size according to precordial electrocardiogram (mapping) and enzyme activity findings].
    Popnikolov S, Tsenov I, Urumov G, Shakhov B, Shubarov K.
    Vutr Boles; 1982 Apr 15; 21(2):98-105. PubMed ID: 7101896
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Clinico-electrocardiographic, morphological and biochemical manifestations of glycoside poisoning in patients with myocardial infarct].
    Popov VG, Smetnev AS, Lazutin VK, Beskrovnova NN, Zhelnov VV.
    Kardiologiia; 1977 Sep 15; 17(9):26-34. PubMed ID: 926596
    [Abstract] [Full Text] [Related]

  • 38. [Protective effect of sodic 3,4,5 trimethoxy-benzoyl-epsilon-amino caproate (C3) in experimental myocardial infarct. 3. Relationship between structure and antipitressin activity in the rat].
    Greggia A, Razzaboni G, Baraldi M, Vergoni W.
    Boll Soc Ital Biol Sper; 1969 Nov 30; 45(22):1449-50. PubMed ID: 5397300
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.